Advertisement
Screener

PHARMAGREEN BIOTECH INC. Pre-Tax Income

PHARMAGREEN BIOTECH INC. Pre-Tax Income

PHARMAGREEN BIOTECH INC. reported Pre-Tax Income of -$2.48 million for the 12-month period ending 2020-09-30, per its 10-K filed 2021-01-08.

Discontinued › Income Statement

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2021-01-08

  • PHARMAGREEN BIOTECH INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-09-30 was -$912.21K.
  • PHARMAGREEN BIOTECH INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-06-30 was -$1.36M.
  • PHARMAGREEN BIOTECH INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2019-09-30 was -$223.45K.
  • PHARMAGREEN BIOTECH INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2019-06-30 was -$58.55K.
  • PHARMAGREEN BIOTECH INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2020 was -$2.48M.
  • PHARMAGREEN BIOTECH INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2019 was -$768.81K.
Period endIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 monthIncome (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month
2020-09-30-$912.21K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-08
-$2.27M
derived: sum of 2 quarters · filed 2021-01-08
-$2.48M
10-K · filed 2021-01-08
2020-06-30-$1.36M
10-Q · filed 2020-08-19
-$1.57M
10-Q · filed 2020-08-19
2019-09-30-$223.45K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-08
-$282.00K
derived: sum of 2 quarters · filed 2021-01-08
-$768.81K
10-K · filed 2021-01-08
2019-06-30-$58.55K
10-Q · filed 2020-08-19
-$545.36K
10-Q · filed 2020-08-19